Boehringer Ingelheim releases ambroxol HCl tablets

Boehringer Ingelheim Korea said it has launched Mucoangin (ambroxol HCl), a troche-type mucolytic agent used in the treatment of respiratory disorders associated with viscid or excessive mucus.

The substance is a mucoactive drug with several properties including secretolytic and secretomotoric actions that restore the physiological clearance mechanisms of the respiratory tract which play an ...